BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zeng DW, Dong J, Liu YR, Jiang JJ, Zhu YY. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol 2016; 22(29): 6663-6672 [PMID: PMC4970475 DOI: 10.3748/wjg.v22.i29.6663]
URL: https://www.wjgnet.com/1007-9327/full/v22/i29/6663.htm
Number Citing Articles
1
Minjie Jiang, Xin Yan, Xinyue Song, Qi Yan, Youyou Zhao, Luyuan Wang, Pujun Gao. Total bile acid to platelet ratioMedicine 2020; 99(22): e20502 doi: 10.1097/MD.0000000000020502
2
Maria Pokorska-Śpiewak, Barbara Kowalik-Mikołajewska, Małgorzata Aniszewska, Magdalena Pluta, Magdalena Marczyńska. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis CBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2462-1
3
思妍 赵. Overview of the Therapeutic Mechanism of Liver Fibrosis Based on Hepatic Stellate CellsAdvances in Clinical Medicine 2022; 12(05): 4810 doi: 10.12677/ACM.2022.125698
4
Xingxiang Liu, Jian Zhou, Liyao Zhu, Xin Zhang, Feng Li. Diagnostic accuracy of apparent diffusion coefficient values combined with γ-glutamyl transpeptidase-to-platelet ratio parameters for predicting hepatitis B-related fibrosisClinics and Research in Hepatology and Gastroenterology 2022; 46(8): 101968 doi: 10.1016/j.clinre.2022.101968
5
Mazen Noureddin, Micaela M Wong, Tsuyoshi Todo, Shelly C Lu, Arun J Sanyal, Edward A Mena. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antiviralsWorld Journal of Gastroenterology 2018; 24(11): 1269-1277 doi: 10.3748/wjg.v24.i11.1269
6
Arshi Khanam, Paul G. Saleeb, Shyam Kottilil. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?Cells 2021; 10(5): 1097 doi: 10.3390/cells10051097
7
D. Liu, J. Li, W. Lu, Y. Wang, X. Zhou, D. Huang, X. Li, R. Ding, Z. Zhang. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis BClinical Microbiology and Infection 2019; 25(4): 514.e1 doi: 10.1016/j.cmi.2018.06.002
8
Mingfa Chen, Zhiguo Wu, Zhan Du, Shuilin Sun, Jun Wu, Jie Luo. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting liver fibrosis in patients with chronic hepatitis B: A meta-analysisGastroenterología y Hepatología (English Edition) 2022; 45(5): 361 doi: 10.1016/j.gastre.2021.10.003
9
Changfei Li, Shousheng Liu, Linlin Lu, Quanjiang Dong, Shiying Xuan, Yongning Xin. Association between Serum Cytokeratin-18 Neoepitope M30 (CK-18 M30) Levels and Chronic Hepatitis B: A Meta-AnalysisHepatitis Monthly 2018; 18(4) doi: 10.5812/hepatmon.64152
10
Maowen Tang, Yuhui Wu, Na Hu, Chong Lin, Jian He, Xing Xia, Meihua Yang, Pinggui Lei, Peng Luo. A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver diseaseScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70891-9
11
Yaqin Zhang, Weihua Cao, Shiyu Wang, Lu Zhang, Xinxin Li, Ziyu Zhang, Yao Xie, Minghui Li. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinomaVirulence 2024; 15(1) doi: 10.1080/21505594.2024.2421231
12
Chun-Li Wang, Chien-Hao Huang, Victor Chien-Chia Wu, Chia-Ling Wu, Yu-Tung Huang, Shang-Hung Chang. Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or CDigestive Diseases and Sciences 2023; 68(6): 2747 doi: 10.1007/s10620-023-07943-z
13
Ju‐Seop Kang, Min‐Ho Lee. Liver Cirrhosis - Update and Current Challenges2017;  doi: 10.5772/intechopen.68317
14
Robert J. Wong, Angelica Le, My T. Nguyen, Huy N. Trinh, Andrew Huynh, My Tops Ly, Huy A. Nguyen, Khanh K. Nguyen, Jenny Yang, Ruel T. Garcia, Brian Levitt, Eduardo da Silveira, Robert G. Gish. Significant Hepatic Fibrosis Among Treatment-Naive Chronic Hepatitis B Virus With Increased Hepatitis B Virus DNA and Normal Alanine AminotransferaseClinical Gastroenterology and Hepatology 2018; 16(1): 146 doi: 10.1016/j.cgh.2017.07.012
15
Tolga Sahin, Ayfer Serin, Ertan Emek, Birkan Bozkurt, Bahadir Turkmen Arikan, Yaman Tokat. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced CirrhosisTransplantation Proceedings 2019; 51(7): 2397 doi: 10.1016/j.transproceed.2019.01.193
16
Yaqiong Chen, Jiao Gong, Wenying Zhou, Yusheng Jie, Zhaoxia Li, Yutian Chong, Bo Hu, Fumio Imazeki. A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis BBioMed Research International 2020; 2020(1) doi: 10.1155/2020/6839137
17
Dmitry V. Garbuzenko. Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infectionMedical Journal of the Russian Federation 2021; 27(4): 373 doi: 10.17816/0869-2106-2021-27-4-373-384
18
Mirella Fraquelli, Ilaria Fanetti, Andrea Costantino. Elastography of the Liver and Beyond2021; : 119 doi: 10.1007/978-3-030-74132-7_9
19
Yi-Ning Dai, Yue-Xing Tu, Di Meng, Mei-Juan Chen, Jia-Jie Zhang, Yu-Han Gong, Yong-Xi Tong, Ming-Shan Wang, Hong-Ying Pan, Hai-Jun Huang. Serum Proteomic Changes as Candidate Biomarkers of Intermediate Liver Fibrosis in Chronic Hepatitis B InfectionOMICS: A Journal of Integrative Biology 2019; 23(3): 167 doi: 10.1089/omi.2018.0179
20
Abdulkerim Özçelik, Mehmet Çelik, Ahmet Şahin, Mehmet Reşat Ceylan, Nevin Güler Dincer. Kronik Hepatit B Hastalarında İnvaziv Ve Non-İnvaziv Karaciğer Fibrozis Göstergelerinin KarşılaştırılmasıHarran Üniversitesi Tıp Fakültesi Dergisi 2024; 21(3): 533 doi: 10.35440/hutfd.1569203
21
Yufeng Xing, Weichao Zhong, Deti Peng, Zhiyi Han, Hua Zeng, Yanqing Wang, Lian Feng, Jinzhen Huang, Linyi Xu, Mingtai Chen, Daqiao Zhou, Kaiping Jiang, Xin Deng, Hua Zhou, Guangdong Tong. Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trialPharmacological Research 2023; 190: 106737 doi: 10.1016/j.phrs.2023.106737
22
Manav Wadhawan. Updates in chronic cholestatic liver diseases: Indian expert recommendations for diagnosing and managing complex casesInternational Journal of Research in Medical Sciences 2025; 13(2): 949 doi: 10.18203/2320-6012.ijrms20250286
23
D.‐P. Liu, W. Lu, Z.‐Q. Zhang, Y.‐B. Wang, R.‐R. Ding, X.‐L. Zhou, D. Huang, X.‐F. Li. Comparative evaluation of GPR versus APRI and FIB‐4 in predicting different levels of liver fibrosis of chronic hepatitis BJournal of Viral Hepatitis 2018; 25(5): 581 doi: 10.1111/jvh.12842
24
Hee Sun Park, Won Hyeok Choe, Hye Seung Han, Mi Hye Yu, Young Jun Kim, Sung Il Jung, Jeong Han Kim, So Young Kwon. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot studyWorld Journal of Gastroenterology 2019; 25(25): 3256-3267 doi: 10.3748/wjg.v25.i25.3256
25
Arshi Khanam, Joel V. Chua, Shyam Kottilil. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease ProgressionInternational Journal of Molecular Sciences 2021; 22(11): 5497 doi: 10.3390/ijms22115497
26
Mingfa Chen, Zhiguo Wu, Zhan Du, Shuilin Sun, Jun Wu, Jie Luo. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting liver fibrosis in patients with chronic hepatitis B: A meta-analysisGastroenterología y Hepatología 2022; 45(5): 361 doi: 10.1016/j.gastrohep.2021.10.001
27
Subham Purkayastha, Ashish K Jha, Ravikant Kumar, Vishwa Mohan Dayal, Sanjeev K Jha. Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis BCureus 2023;  doi: 10.7759/cureus.33744